(Q33187534)

English

Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 July 2017

Group II mGlu receptor activation suppresses norepinephrine release in the ventral hippocampus and locomotor responses to acute ketamine challenge (English)

1 reference

Europe PubMed Central

23 July 2017

0 references

Daniel S Lorrain

1

object named as

Daniel S Lorrain

1 reference

Europe PubMed Central

23 July 2017

author name string

Hervé Schaffhauser

2

1 reference

Europe PubMed Central

23 July 2017

Una C Campbell

3

1 reference

Europe PubMed Central

23 July 2017

Christopher S Baccei

4

1 reference

Europe PubMed Central

23 July 2017

Lucia D Correa

5

1 reference

Europe PubMed Central

23 July 2017

Blake Rowe

6

1 reference

Europe PubMed Central

23 July 2017

Dana E Rodriguez

7

1 reference

Europe PubMed Central

23 July 2017

Jeffery J Anderson

8

1 reference

Europe PubMed Central

23 July 2017

Mark A Varney

9

1 reference

Europe PubMed Central

23 July 2017

Anthony B Pinkerton

10

1 reference

Europe PubMed Central

23 July 2017

Jean-Michel Vernier

11

1 reference

Europe PubMed Central

23 July 2017

Linda J Bristow

12

1 reference

Europe PubMed Central

23 July 2017

language of work or name

0 references

publication date

25 June 2003

1 reference

Europe PubMed Central

23 July 2017

Neuropsychopharmacology

1 reference

Europe PubMed Central

23 July 2017

28

1 reference

Europe PubMed Central

23 July 2017

9

1 reference

Europe PubMed Central

23 July 2017

1622-1632

1 reference

Europe PubMed Central

23 July 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300238

0 references

Effect of clozapine, haloperidol, or M100907 on phencyclidine-activated glutamate efflux in the prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

α 2 -Adrenoceptor-Mediated Hyperpolarization of Locus Coeruleus Neurons: Intracellular Studies in Vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Alpha-1-adrenergic receptors mediate sensorimotor gating deficits produced by intracerebral dizocilpine administration in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Plasma norepinephrine in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Noradrenergic mechanisms in stress and anxiety: II. Clinical studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Efferent connections of the medial prefrontal cortex in the rabbit.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical Findings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Librium prevents the analgesia and shuttlebox escape deficit typically observed following inescapable shock.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Modulation of excitatory synaptic transmission in locus coeruleus by multiple presynaptic metabotropic glutamate receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Norepinephrine in Chronic Paranoid Schizophrenia: Above-Normal Levels in Limbic Forebrain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

The hippocampus as a possible site of action for increased locomotion during intracerebral infusions of norepinephrine.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Effects of sedatives on noradrenaline release from the medial prefrontal cortex in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Inhibitory effect of clonidine on ketamine-induced norepinephrine release from the medial prefrontal cortex in rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Pharmacological properties of native metabotropic glutamate receptors in freshly dissociated Golgi cells of the rat cerebellum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Schizophrenia: elevated cerebrospinal fluid norepinephrine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Destruction of the locus coeruleus decreases physical signs of opiate withdrawal.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Systemic PCP treatment elevates brain extracellular 5-HT: a microdialysis study in awake rats.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Single unit activity of locus coeruleus neurons in the freely moving cat. II. Conditioning and pharmacologic studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

II. New evidence for a locus coeruleus-norepinephrine connection with anxiety

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Behavioral activation of rats during intraventricular infusion of norepinephrine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Efferent projections of the infralimbic (area 25) region of the medial prefrontal cortex in the rat: an anterograde tracer PHA-L study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Involvement of the brain noradrenaline system in emotional changes caused by stress in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

The selective mGlu2/3 receptor agonist LY354740 attenuates morphine-withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Involvement of gamma-aminobutyric acid neurotransmission in phencyclidine-induced dopamine release in the medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

21 January 2018

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

7 January 2021

based on heuristic

inferred from DOI database lookup

Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro binding characteristics of a new selective group II metabotropic glutamate receptor radioligand, [3H]LY354740, in rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

7 January 2021

based on heuristic

inferred from DOI database lookup

Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

7 January 2021

based on heuristic

inferred from DOI database lookup

Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300238

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1300238

1 reference

Europe PubMed Central

23 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

23 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33187534&oldid=1537403019"